PSD 3 Exam I

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/90

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

91 Terms

1
New cards

Ambulatory care pharmacy practice

The provision of integrated, accessible health care services by pharmacists who are accountable for addressing medication needs, developing sustained partnerships with patients, and practicing in the context of family and community.

2
New cards

History of ambulatory care pharmacy - 1960s

Increased recognition of the benefits of optimizing medication use and efforts shifted toward reducing medication-related morbidity and mortality.

3
New cards

History of ambulatory care pharmacy - 1970s

Task force created to develop national standards for pharmacists' clinical practice.

4
New cards

History of ambulatory care pharmacy - 1980s

Multi-institutional pharmacy system was divided into inpatient and ambulatory care practices; ambulatory care practice increased within the Dept. of Veterans Affairs.

5
New cards

History of ambulatory care pharmacy - 1990s

CMS published a report stating that 'clinical pharmacy services add value to care for both institutional and ambulatory patients'; Asheville Project in North Carolina.

6
New cards

History of ambulatory care pharmacy - 2000s

Certification created by BPS for ambulatory care pharmacy (exam debut in 2011).

7
New cards

Opportunities for ambulatory care practice

- Improvement of clinical and economic outcomes
- optimizing safe medication use
- optimizing diabetes, asthma, cardiovascular disease, and renal disease care
- optimizing preventative care
- implementing precision therapeutics
- expanding medication therapy management
- mitigating health care disparities.

8
New cards

Role of an Ambulatory Care Pharmacist

- Direct Patient Care
- Collaboration with other Healthcare Team Members
- Patient and Provider Education
- Quality Improvement

9
New cards

Diabetes quality measure goal

Goal to have >70% of patients with an A1c <9.0%.

10
New cards

Primary Care Ambulatory Care Pharmacist Daily Routine

1. Patients in Clinic to see Provider
2. Patient Visits with Pharmacist
3. PPCP
4. Document
5. Drug Info Resources
6 Education

11
New cards

Pharmacist Telemedicine Visit-Diabetes

Call patient to review home blood glucose readings, lifestyle, medications, and adherence; obtain blood glucose readings and document in excel; confirm adherence to medications and any recent medication changes; review diet and exercise, provide education on improvements; make any appropriate medication changes, educate patient on changes and monitoring; set follow-up visit; document visit using SOAP note and forward to provider.

12
New cards

Pharmacist In Person Visit-HTN

Review all medications with patient to determine current regimen and adherence; review home blood pressure readings if available; review lifestyle factors contributing to hypertension; check patient blood pressure in office using correct technique; make any appropriate medication changes, educate patient on changes and monitoring; provide any lifestyle education; set follow-up visit; document visit using SOAP note and forward to provider.

13
New cards

Object drug

The drug that is affected by the interaction.

14
New cards

Precipitant drug

The drug that causes the interaction.

15
New cards

Pharmacokinetic interactions

Occur when the absorption, distribution, metabolism, or excretion (ADME) of a drug is affected.

16
New cards

Absorption interactions

Those that affect the RATE of drug absorption are usually NOT clinically significant unless an immediate effect is needed; those that affect the EXTENT of drug absorption (bioavailability) MAY be more significant.

17
New cards

Metabolism interactions

These tend to be the most clinically significant; enzyme inducing drugs increase the production and activity of the enzyme that metabolizes the drug, while enzyme inhibiting drugs cause the drug to be cumulated in the body.

18
New cards

Distribution interactions

In general, not clinically significant because the object drug is bonded to the plasma tends to knock out and be free which means it could get eliminated.

19
New cards

Pharmacodynamic interaction

Pharmacologic / Additive effects such as additive CNS depression, additive hypotensive effects, additive anticholinergic effects, changes in various components of the coagulation system, changes in potassium levels, drugs that prolong the QT interval.

20
New cards

Risk factors impacting drug interaction significance

Narrow therapeutic index, duration of therapy, mechanism of action, dose related.

21
New cards

Management strategies for drug interactions

Temporarily discontinue one of the drugs if possible, dose change, change the time of drug administration, choose an alternative therapy if appropriate, monitor the patient, reevaluate risk when drug therapy is changed or stopped, avoid use of contraindicated drugs.

22
New cards

Drug Info Resources

Sources for drug interaction and safety information.

23
New cards

Facts & Comparisons

Online database for drug monographs and interactions.

24
New cards

Lexicomp Online

Comprehensive drug information and interaction screener.

25
New cards

Micromedex

Database providing drug monographs and interactions.

26
New cards

AHFS

American Hospital Formulary Service, drug monograph listings.

27
New cards

Martindale

Complete drug reference with monograph listings.

28
New cards

Drug Information Handbook

Lexicomp's handbook for drug information.

29
New cards

ADR Resources

Resources identifying adverse drug reactions and safety.

30
New cards

Clin-Alert

Resource for alerts on drug reactions and safety.

31
New cards

Reactions Weekly

Weekly publication on drug reactions and safety issues.

32
New cards

Natural Medicines

Resource for herbal and dietary supplement information.

33
New cards

Hansten & Horn

Resource detailing top drug interactions.

34
New cards

PPCP

Pharmacists' Patient Care Process framework.

35
New cards

Collect

Gather patient information for medication history.

36
New cards

Assess

Evaluate collected information for therapy effectiveness.

37
New cards

what is the assessment statement?

[PROBLEM, severity, status] secondary to [CAUSE/ETIOLOGY] as evidenced by [RELATED S & O EVIDENCE]

38
New cards

Plan

Create patient-centered care plans collaboratively.

39
New cards

Implement

Execute care plans with healthcare professionals.

40
New cards

Follow-up

Monitor and evaluate care plan effectiveness.

41
New cards

Sterile Technique

Method to maintain a microorganism-free environment.

42
New cards

Infection Control

Precautions to prevent infection during vaccinations.

43
New cards

Hand Washing

Essential hygiene before patient interactions.

44
New cards

Gloving

Recommended to prevent contamination during procedures.

45
New cards

Syringe Sterility

Syringes must remain sterile until use.

46
New cards

Screening

Assess patients for vaccine contraindications.

47
New cards

Vaccine Safety Communication

Discuss benefits and risks of vaccines openly.

48
New cards

Needle Selection

Choose needle based on vaccine route and viscosity.

49
New cards

Syringe Filling

Proper technique for filling syringes with vaccine.

50
New cards

Patient Positioning

Ensure patient is seated and relaxed during vaccination.

51
New cards

Needle Gauge for IM

Use 22 to 25-gauge needles for intramuscular injections.

52
New cards

Needle Length for IM

Length varies by patient age and size.

53
New cards

Subcutaneous Injection Technique

Inject at a 45-degree angle into fatty tissue.

54
New cards

Needle Gauge for SubQ

Use 23 to 25-gauge needles for subcutaneous injections.

55
New cards

Disposal Procedures

Dispose of needles in puncture-proof containers.

56
New cards

Accidental Needle Sticks

Immediate washing and reporting of needle stick injuries.

57
New cards

Describe the Pharmacists' Patient Care Process

Collect
Assess
Plan
Implement
Follow-up

58
New cards

What is the needle size for a subcutaneous injection for all ages?

5/8 inch

59
New cards

What is the needle size for IM injections in neonates?

5/8 inch

60
New cards

What is the needle size for IM injections in children aged 1-12 months?

1 inch

61
New cards

What is the needle size for IM injections in children aged 1-10 years --> thigh?

1-1.25 inch

62
New cards

What is the needle size for IM injections in children aged 1-10 years --> deltoid muscle?

5/8-1 inch

63
New cards

What is the needle size for IM injections in adolescents aged 11-18 years?

5/8-1 inch

64
New cards

What is the needle size for IM injections in adults under 152 lbs?

1 inch

65
New cards

What is the needle size for IM injections in men weighing 152-260 lbs?

1-1.5 inch

66
New cards

What is the needle size for IM injections in women weighing 152-200 lbs?

1-1.5 inch

67
New cards

What is the needle size for IM injections in men over 260 lbs?

1.5 inch

68
New cards

What is the needle size for IM injections in women over 200 lbs?

1.5 inch

69
New cards

Review of disposal procedures for contaminated needles

- Position sharps container within reach where risk of needlesticks is minimized
- Pharmacist should not cross their body to deposit the syringe in the sharps container after the injection.
- NEVER recap a contaminated needle

70
New cards

Proper procedures for accidental needle sticks

1. Wash needle-stick injuries with soap and water immediately.
2. Report the exposure right away and seek medical treatment.
3. Discuss the risks of acquiring HBV, HCV, and HIV, and consider the need for post-exposure treatment.
4. Follow-up testing is available for all workers concerned about possible infection.
5. Follow the workplace or organization's policies and procedures for needle-stick injuries.

71
New cards

what are drugs that are enzyme inducers?

• carbamazepine
• phenobarbital
• phenytoin
• rifampin
• St. John's Wort

72
New cards

what drugs are enzyme inhibitors?

• amiodarone
• clarithromycin
• diltiazem
• fluconazole
• itraconazole

73
New cards

List the background information that might be needed to answer a drug interaction question

- Patient specific information (age/weight/height…)

- Patient’s other medical problems

- Indication for the drugs

- Expected duration of therapy

- Dosage / Route / Frequency

- When were the drugs were started? (or when will they be?)

- Other medications

74
New cards

Discuss risk factors that might impact the clinical significance of a drug interaction

1. Not all interactions are clinically signifigant
2. Does the drug that have a narrow therapeutic index
3. Duration of therapy
4. Mechanism of the interaction
5. Is it dose related
6. What is expected to occur in the patient
7. Timing: When does interaction start/go away
8. Level of evidence

75
New cards

Provide the ASHP's definition of adverse drug reaction (ADR)

An unexpected, unintended, undesired, or excessive response to a medication

76
New cards

Medication misadventures

- Any iatrogenic hazard or incident associated with medications
- Always unexpected or undesirable to patient and health professional

77
New cards

ADE

Any injury caused by a medication

78
New cards

ADR

An unexpected, unintended, undesired, or excessive response to a medication

79
New cards

Medication error:

Any preventable event that has the potential to lead to inappropriate medication use or patient harm while the medication is in the control of the health care professional, patient, or consumer

80
New cards

Describe the various ways adverse drug reactions are classified

Classification by SEVERITY, MECHANISM, PROBABILITY

81
New cards

Discuss factors that contribute to the assessment of causality

Timing: Did the effect appear soon after starting a drug/increasing dose?

Dechallenge: Did the effect go away after stopping drug/decreasing dose?

Rechallenge: Did the effect appear again if the drug was given after a period of the drug being out of the system?

82
New cards

Describe the purpose and usefulness of ADR causality algorithms

Promote a consistent systematic evaluation process

Common algorithms:

Naranjo (1981) 10 questions / score

Jones (1982) series of Y/N questions

Liverpool (CAT) series of questions

83
New cards

Discuss appropriate background information needed to answer ADR drug information questions

1.Complete description of reaction

2.Information about drug (dose, duration, route, preparation)

3.Patient information (pharmacokinetic alterations, age, genetic background, allergy history, other medications, indication for drug)

84
New cards

how to manage chronic disease management

Coordinated healthcare interventions and communications aimed at reducing healthcare costs, enhancing quality of life, preventing or minimizing disease effects

85
New cards

Discuss the role of the pharmacist in chronic disease management

• Assist in the identification of individuals
• Assist with medication adherence
• Conduct disease state monitoring
• Provide direct patient care
• Provide patient education
• Evaluate outcomes of programs

86
New cards

Define population health

Interdisciplinary, customizable approach that allows health departments or facilities to connect practice to policy and allow local change

Health outcomes of a group of individuals including the distribution of such outcomes within the group

87
New cards

Define collaborative practice agreements

A formal agreement in which a licensed provider makes a diagnosis, supervises patient care, and refers patients to a pharmacist under a protocol that allows the pharmacist to perform specific patient care functions.

88
New cards

What is a collaborative practice agreement

• Pharmacist and physician enter into a legal agreement • Agreement allows pharmacist to manage agreed upon conditions • Agreements are specific in what the pharmacist can do • Pharmacist becomes an extension of the provider and collaborator in patient care

89
New cards

Describe collaborative practice agreement legislation in the United States

- Pharmacists don't have to be in a consult agreement to bill for certain services anymore
- Pharmacists have their own provider ID that they use to bill Medicaid's

90
New cards

Describe collaborative practice agreement legislation in Ohio

Pharmacists can now enter into a consult agreement with Physician assistants, Clinical nurse specialists, certified nurse-midwives, or certified nurse practitioners if authorized by a supervising or collaborating physician

91
New cards

Identify strategies to implement collaborative practice agreements into practice

1. Create and expand infrastructure
2. Use simple, understandable, and empowering language
3. Allow providers to define details of each agreement
4. Examine and redesign professional scope of practice
5. Properly align incentives
6. Use technology to improve patient care
7. Maintain strong, trusting, and mutually beneficial relationships